Type 2 Diabetes Mellitus Therapeutics Market 2022
Type 2 Diabetes Mellitus Therapeutics Market 2022

Опубликовано 31 May 2017 в "Бизнес", язык - English. 6 страниц.

Описание публикации:

The current South-East Asia T2DM market contains novel products, including Jardiance, a SGLT-2 inhibitor; Victoza, a GLP-1 receptor agonist; and Januvia, a DPP-4 inhibitor. Еще

Читать

Бесплатно

Type 2 Diabetes Mellitus Therapeutics Market 2022 Type 2 Diabetes Mellitus Therapeutics Market 2022

Сопутствующие Журналы

Type 2 Diabetes Mellitus Therapeutics Market 2022
Type 2 Diabetes Mellitus Therapeutics Market 2022